CHRISTOPHER YOUNG: Open Payments
NPI 1447981485 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 129 payments from 29 companies in 2025. Trend: 2023 $41 · 2024 $435 · 2025 $2,219
Food & beverage: $2,219
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $225 |
| Lilly USA, LLC | 17 | $214 |
| AstraZeneca Pharmaceuticals LP | 8 | $198 |
| Novo Nordisk Inc | 11 | $172 |
| Lundbeck LLC | 13 | $156 |
| Phathom Pharmaceuticals, Inc. | 8 | $154 |
| Janssen Pharmaceuticals, Inc | 7 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $95 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $87 |
Products named: REXULTI, VOQUEZNA, MOUNJARO, SPRAVATO, VRAYLAR, AIRSUPRA, Kerendia, CAPLYTA.
Industry payments across VA — which companies pay providers there.
